← Back to patent-cliff list
CAS 1392109-02-2
4,6-dimethoxy-1,3,5-triazin-2-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate
Codes：GLYC-008
Application context (from source-drug indications)
哮喘布地奈德/富马酸福莫特/格隆溴铵慢性阻塞性肺疾病布地奈德/富马酸福莫特/格隆溴铵慢性阻塞性肺疾病马来酸茚达特罗/格隆溴铵
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 布地奈德/富马酸福莫特/格隆溴铵Budesonide/Formoterol fumarate/Glycopyrronium Bromide | Tier B — Position early | - |
| 马来酸茚达特罗/格隆溴铵Indacaterol Maleate/Glycopyrronium Bromide | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-cyclopentyl-2-hydroxy-2-phenylacetic acid→1-methylpyrrolidin-3-ol→2-chloro-4,6-dimethoxy-1,3,5-triazine→4,6-dimethoxy-1,3,5-triazin-2-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate→1-methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate
2-cyclopentyl-2-hydroxy-2-phenylacetic acid→1-methylpyrrolidin-3-ol→2-chloro-4,6-dimethoxy-1,3,5-triazine→4,6-dimethoxy-1,3,5-triazin-2-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate→1-methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.